|
Orgenesis Inc Net Income per Employee
ORGS's Quarterly Results, Trends, Rankings, Statistics
Orgenesis Inc 's Income per employee grew in the second quarter 2023 on a trailing twelve month basis to $ 95,514, the income was higher than average, indicating higher productivity of the company's employees. The Healthcare sector has seen employees of 29 other companies achieving higher income per employee. While Orgenesis Inc 's total ranking has deteriorated compared to the previous quarter from 644 to 787.
What is Income per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
ORGS Net Income per Employee |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
Y / Y Net Income Change |
-33.34 % |
6.6 % |
-74.65 % |
-86.13 % |
101.54 % |
Net Income per Employee (TTM) $ |
95,514 |
112,009 |
109,631 |
143,378 |
222,144 |
ORGS's Total
Ranking |
# 787 |
# 644 |
# 751 |
# 0 |
# 0 |
Seq. Net Income Change |
-14.08 % |
234.98 % |
-9.66 % |
-74.36 % |
37.4 % |
Net Income per Employee Statistics |
High |
Average |
Low |
$ 279,973 |
$ 46,897 |
$ -517,414 |
(Aug 31 2018) |
|
(Mar 31 2020) |
News about Orgenesis Inc |
Orgenesis Consortium Awarded 2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing GERMANTOWN, Md., Feb. 29, 2024 - Orgenesis Inc. (Nasdaq:ORGS), the world-renowned global leader in decentralized cell and gene therapies (CGTs), proudly announces that its consortium has been honored with a significant 2.0 million euro grant from the esteemed Walloon Government in Belgium. This prestigious grant, titled Monitoring with AI of Decentralized ATMP Manufacturing (MAIDAM), marks a significant milestone in revolutionizing the field of advanced therapy medicinal products (ATMPs) and propels Orgenesis' presence as an industry frontrunner. The consortium, comprising Orgenesis Services Belgium, Université catholique de Louvain (UCLouvain) / TRusted AI Labs (TRAIL), and DNAlytics, brings together a collective of pioneering minds and cutting-edge expertise. ATMPs represent the zenith of innovation in biomedicines and promise tremendous potential in addressing unmet medical needs through a range of therapies, including cell, gene, exosome, and phage-based treatments.
|
Companies with similar Income per Employee for 12 month ending Jun 30 2023, within Healthcare Sector | Income per Employee | Income 12 month ending Jun 30 2023 | Number of Employees Jun 30 2023 | Intuitive Surgical Inc | 147,881.14 | $ 1,448.200 Million | 9,793 | Maravai Lifesciences Holdings Inc | 124,136.43 | $ 173.791 Million | 1,400 | Resmed Inc | 109,994.61 | $ 897.556 Million | 8,160 | Bio techne Corp | 95,147.33 | $ 285.442 Million | 3,000 | Johnson and Johnson | 92,124.21 | $ 13,054.000 Million | 141,700 | Edwards Lifesciences Corporation | 88,401.27 | $ 1,387.900 Million | 15,700 | Organon and Co | 81,075.27 | $ 754.000 Million | 9,300 | Idexx Laboratories Inc | 76,467.15 | $ 791.435 Million | 10,350 | Ufp Technologies Inc | 68,731.30 | $ 49.624 Million | 722 | Agilent Technologies inc | 62,596.69 | $ 1,133.000 Million | 18,100 | Carlisle Companies Incorporated | 60,433.33 | $ 725.200 Million | 12,000 | Stryker Corp | 58,891.30 | $ 2,709.000 Million | 46,000 | Dexcom Inc | 56,746.03 | $ 357.500 Million | 6,300 | West Pharmaceutical Services Inc | 51,535.02 | $ 518.700 Million | 10,065 | Viatris Inc | 50,113.51 | $ 1,854.200 Million | 37,000 | Mettler toledo International Inc | 49,931.69 | $ 888.784 Million | 17,800 |
Date modified: 2023-08-21T10:45:04+00:00
|